Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

To give some idea of the sheer size of Johnson & Johnson, a glance at its reported sales figure is revealing. In the fourth ...

Kenvue Inc . (NYSE:KVUE), the consumer health company spun off from Johnson & Johnson in 2023, finds itself at a critical juncture as it navigates its first full year as an independent entity. The ...

Kenvue Inc. closed 12.96% below its 52-week high of $24.46, which the company reached on November 26th.

Government agencies have challenged J&J's bankruptcy proposal, which includes $8 Billion for around 60,000 asbestos ovarian cancer lawsuits.

Kenvue Inc. (KVUE), a global consumer health company, is dedicated to delivering trusted personal care, health, and wellness ...

Barclays analyst Lauren Lieberman maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report) today and set a price target of $21.00. The ...

Read here for an update on Yacktman Asset Management's portfolio changes, top holdings, and performance compared to market ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Check the time stamp on this data. Updated AI-Generated Signals for Kenvue Inc. (KVUE) available here: KVUE. Type a few symbols and Take a Trial. The signals for these will appear immediately on your ...